Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 9, 1985 - Issue 6
19
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Hemoglobin North Chicago (β36 [C2] Proline → Serine): A New High Affinity Hemoglobin

, , &
Pages 559-576 | Received 23 Jul 1985, Accepted 26 Sep 1985, Published online: 07 Jul 2009
 

Abstract

Hemoglobin North Chicago, β36 [C2] Pro → Ser is a new high oxygen affinity hemoglobin variant. It was discovered in a 52-year-old male with erythrocytosis since age 20 who had been treated with different regimens for polycythemia vera including several courses of 32P. The variant is electrophoretically silent with normal stability and increased oxygen affinity (P50 16.6 mm Hg at 37°C., pH 7.4). Characterization of the structure of hemoglobin North Chicago involved the use of HPLC, secondary ion mass spectral analysis of the tryptic peptides and conventional fingerprinting. Hemoglobin North Chicago manifested bizarre hydrophobicity of its β-chains, as demonstrated by reverse phase HPLC and Triton X-100 electrophoresis. This behavior is not expected from the substitution of proline to serine. Proline residue β36 [C2] is one of the invariant residues of the β-chains of all known mammals and most vertebrates. This residue is involved in the α1 β2 contacts of hemoglobin molecule and its substitution to serine is possibly associated with conformational changes and alteration of hemoglobin function.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.